Research Grant Program supports investigators pursuing basic, translational, and clinical research to deepen understanding of Prader-Willi and Schaaf-Yang syndromes and accelerate meaningful treatments.
Funder: Foundation for Prader-Willi Research
Due Dates: September 4, 2026 (Fall LOI) | November 13, 2026 (Fall proposal) | February 26, 2027 (Spring LOI) | May 14, 2027 (Spring proposal)
Funding Amounts: Up to $150,000 USD in direct costs for 18 months, with optional competitive 18-month renewal and up to 8% indirect costs
Summary: Supports innovative basic, translational, and clinical research advancing understanding and treatments for Prader-Willi and Schaaf-Yang syndromes.
Key Information: Principal Investigators must hold a primary faculty appointment at Instructor level or higher.
The Foundation for Prader-Willi Research (FPWR) supports high-impact research that advances understanding of Prader-Willi syndrome (PWS) and Schaaf-Yang syndrome (SYS) and accelerates meaningful treatments. Through two competitive grant cycles each year, the program funds basic, translational, and clinical research by investigators worldwide. It encourages bold ideas, new collaborations, and innovative, high-risk/high-reward projects with potential to improve the lives of people with these conditions.
FPWR particularly supports work developing and evaluating therapeutic approaches with potential for near-term benefit, alongside research producing significant advances in understanding these disorders. Priorities span genetics, hunger and metabolism, cognition and mental health, clinical care, and therapeutic development. Early-career investigators, established researchers entering the field, pilot studies, proof-of-concept research, and collaborative therapeutic teams are especially well suited to the program.